王旭 , 茹彦海 , 罗冬平 , 郭晓凯 , 徐家云 . 疫苗在血液透析患者中的应用[J]. 中国血液净化, 2021 , 20(05) : 336 -339 . DOI: 10.3969/j.issn.1671-4091.2021.05.012

[1]Wang F, Yang C, Long J, et al.Executive summary for the 2015 Annual Date Report of the China Kidney Disease Network(CK-NET)[J].Kidney Int, 2019, 95(3):501-505 [2]Cui FQ, Shen LP, Li L, et al.Prevention of chronic Hepatitis B after 3 decades of escalating vaccination policy,China[J].Emerg Infect Dis, 2017, 23(5):765-772 [3]Udomkarnjananun S, Takkavatakarn K, Praditpornsilpa K, et al.Hepatitis B virus vaccine immune response and mortality in dialysis patients:a meta-analysis[J].J Nephrol, 2019, 33(6):343-354 [4]Ghadiani MH, Besharati S, Mousavinasab N, et al.Response rates to HB vaccine in CKD stages 3~4 and hemodialysis patients[J].J Res Med Sci, 2012, 17(6):527-33 [5]中华医学会感染病学分会，中华医学会肝病学分会.慢性乙型肝炎防治指南（2019年版）[J].中华传染病杂志, 2019, 37(12):711-736 [6]中华预防医学会, 中国疾病预防控制中心免疫规划中心.中国成人乙型肝炎免疫预防技术指南[J].中华流行病学杂志, 2011, 32(12):1119-1203 [7]Schillie S, Vellozzi C, Reingold A, et al.Prevention of Hepatitis B Virus Infection in the United States:Recommendations of the Advisory Committee on Immunization Practices[J].MMWR Recomm Rep, 2018, 67(1):1-31 [8]Feng YL, Shi XH, Shi J, et al.Immunogenicity,antibody persistence,and safety of the 60ug hepatitis B vaccine in hemodialysis patients:a multicenter,randomized,double-blind,parallel-controlled trial[J].Expert Rev Vaccines, 2017, 16(10):1045-1052 [9]Wu ZK, Bao HD, Yao J, et al.Suitable hepatitis B vaccine for adult immunization in China:a systematic review and meta-analysis[J].Hum Vacc Immunother, 2019, 15(1):220-227 [10]梁贞贞, 邵彦, 王慎玉, 等.成人接种汉逊酵母乙型肝炎疫苗 （CpG ODN佐剂）的安全性及免疫原性:Ⅰ期临床试验初步结果[J].中华预防医学杂志, 2020, 54(8):854-860 [11]Jassen RS, Mangoo-Karim R, Pergola PE, et al.Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant(HBsAg-1018)compared with a licensed hepatitis B vaccine in patients with chronic kidney disease[J].Vaccine, 2013, 31(46):5306-5313 [12]Nongnuch A, Ngampongpan W, Srichatrapimuk S, et al.Immune response to influenza vaccination in ESRD patients undergoing hemodialysis vshemodiafiltration[J].PLoS One, 2020, 15(2):e0227719-e0227719 [13]Butler AM, Layton JB, Dharnidharka VR, et al.Comparative effectiveness of high-dose versus standard-dose influenza vaccine among patients receiving maintennace hemodialysis[J].Am J Kidney Dis, 2019, 75(1):71-83 [14]Miskulin DC, Weiner DE, Tighiouart H, et al.High-dose seasonal influenza vaccine in patients undergoing dialysis[J].Clin J Am Soc Nephrol, 2018, 13(11):1703-1711 [15]Tanzi E, Amendola A, Pariani E, et al.Lack of effect of a booster dose of influenza vaccine in hemodialysis patients[J].J Med Virol, 2007, 79(8):1176-1179 [16]Noh YJ, Song JY, Choi WS, et al.Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis:MF59-adjuvanted versus non-adjuvanted vaccines[J].Hum Vaccin Immunother, 2016, 12(11):2902-2908 [17]中华预防医学会, 中华预防医学会疫苗与免疫分会.肺炎球菌性疾病免疫预防专家共识版[J].中华流行病学杂志, 2020, 41(12):2005-2039 [18]Matanock A, Lee G, Gierke R, et al.Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged≥65years:updated recommendations of the Advisory Committee on Immunization Practices(ACIP)[J].Morbidity and Mortality Weekly Report, 2019, 64(46):1069-1075 [19]龚洋, 罗树权, 李国晏.新型肺炎链球菌疫苗研究进展[J].微生物学免疫学进展, 2020, 48(1):75-81 [20]何奔, 向泽林, 沈国初, 等.老年人单独及联合接种流感疫苗、价肺炎球菌多糖疫苗的安全性评价[J].中华微生物和免疫学杂志, 2018, 38(4):293-299 [21]Mo YN, Zeng JH, Xiao CX, et al.Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients:A systematic review and meta-analysis[J].Vaccine, 2020, 38(47):7422-7432